MiniMed Group, Inc. (MMEDV) Guidance & Earnings Results
On 2026-09-01 MiniMed Group, Inc. raised guidance: "FY27 organic revenue growth raised to ~10.5% from ~10%; FY27 adjusted EBITDA margin ~16%…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
MMEDVMiniMed Group, Inc.Follow MMEDV — free
—
Price chart with a free account
- Market cap
- —
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 1 Sep 26 | Raised | FY27 organic revenue growth raised to ~10.5% from ~10%; FY27 adjusted EBITDA margin ~16% (reaffirmed) · full year |
| 3 Jun 26 | Raised | FY27 organic revenue growth ~10% (including 1.0-1.5% extra week benefit); FY27 adjusted EBITDA margin ~16% · full year |
MiniMed Group, Inc. — questions
- What guidance did MiniMed Group, Inc. give?
- On 2026-09-01: "FY27 organic revenue growth raised to ~10.5% from ~10%; FY27 adjusted EBITDA margin ~16% (reaffirmed)"
- When does MiniMed Group, Inc. report earnings?
- MiniMed Group, Inc.'s next earnings report is expected on 2026-11-16.
Every figure on this page comes from MiniMed Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.